CD14 expression in the first 24h of sepsis: Effect of -260C>T CD14 SNP

Immunological Investigations

Volumn 37, Issue 8, 2008, Pages 752-769

  Butkus De Aguiar, Bibiana ^a   Girardi, Ingrid ^a   D'Avila Paskulin, Diego ^a   De Franca, Everaldo ^a   Dornelles, Claudia ^a   Suparregui Dias, Fernando ^a   Bonorino, Cristina ^a   Sampaio Alho, Clarice ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

260C>T CD14 SNP; MCD14; SCD14; Sepsis

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 57349151602     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130802403242     Document Type: Article

References (37)

1. ACCP-SCCM. Anonymous. (1992). American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
2. Agnese, D.M., Calvano, J.E., Hahm, S.J., Coyle, S.M., Corbett, S.A., Calvano, S.E., Lowry, S.F. (2002). Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186:1522-1525.
3. Baldini, M., Lohman, C., Halonen, M., Erickson, R.P., Holt, P.G., Martinez, F.D. (1999). A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respirat. Cell Mol. Biol. 20:976-983.
4. Barber, R.C., Aragaki, C.C., Chang, L.E., Purdue, G.F., Hunt, J.L., Arnoldo, B.D., Horton, J.W. (2007). CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock 27(3):232-237.
5. Barber, R.C., Chang, L.E., Arnoldo, B.D., Purdue, G.F., Hunt, J.L., Horton, J.W., Aragaki, C. C. (2006). Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res. 4:250-255.
6. Brunialti, M.K.C., Martins, P.S., Carvalho, H.B., Machado, F.R., Barbosa, L.M., Salomao, R. (2006). TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25(4):351-357.
7. Burgmann, H., Winkler, S., Locker, G.J., Presterl, E., Laczika, K., Staudinger, T., Knapp, S., Thalhammer, F., Wenisch, C., Zedwitz-Liebenstein, K., Frass, M., Graninger, W. (1996). Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin. Immunol. Immunopathol. 80:307-310.
8. Calvano, J.E., Agnese, D.M., Um, J.Y., Goshima, M., Singhal, R., Coyle, S.M., Reddell, M.T., Kumar, A., Calvano, S.E., Lowry, S.F. (2003). Modulation Of The Lipopolysaccharide Receptor Complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 20(5):415-419.
9. Carrillo, E.H., Gordon, L., Goode, E., Davis, E., Polk, H.C. (2001). Early elevation of soluble CD14 may help identify trauma patients at high risk for infection. J. Trauma 50:810-815.
10. D'avila, L.C., Albarus, M.H., Franco, C.R., Aguiar, B.B., Oliveira, J.R., Dias F.D., Alho, C.A. (2006). Effect of CD14 -260C>T polymorphism on the mortality of critically ill patients. Imm. Cell Biol. 84:342-348.
11. Dziarsky, R., Tapping, R.I., Tobias, P.S. (1998). Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680-8690.
12. Ertel, W., Kremer, J.P., Steckholzer, U., Jarrar, D., Trentz, O., Schildberg, F.W. (1995). Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347.
13. Gibot, S., Cariou, A., Drouet, L., Rossignol, M., Ripoll, L. (2002). Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit. Care Med. 30:969-973.
14. Glück, T., Silver, J., Epstein, M., Cao, P., Farber, B., Goyert, S.M. (2001). Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur. J. Med. Res. 6:351-358.
15. Goyert, S.M., Ferrero, E., Rettig, W.J., Yenamandra, A.K., Obata, F., Le Beau, M.M. (1988). The CD14 monocyte differentiation antigen maps to region encoding growth factors and receptors. Science 239: 497-500.
16. Heesen, M., Bloemeke, B., Schade, U., Obertacke, U., Majetschak, M. (2002). The ?260-C>T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intens. Care Med. 28:1161-1163.
17. Heesen, M., Blömeke, B., Schlüter, B., Heussen, N., Rossaint, R., Kunz, D. (2001). Lack of association between the -260 C - >T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Inten. Care Med. 27(11):1770-1775.
18. Hiki, N., Berger, D., Prigl, C., Boelke, E., Wiedeck, H., Seidelmann, M., Staib, L., Kaminishi, M., Oohara, T., Beger, H.G. (1998). Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. Infect. Immun. 66:1135-1141.
19. Hubacek, J.A., Pit'ha, J., Skodová, Z., Stanek, V., Poledne, R., Schmitz, G. (1999). C(?260) a T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99:3218-3220.
20. Hubacek, J.A., Stuber, F., Frohlich, D., et al. (2000). The common functional C(?159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun. 1:405-407.
21. Jersmann, H.P.A. (2005). Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol. Cell Biol. 83: 462-467.
22. Karhukorpi, J., Yan, Y., Niemelä, S., Valtonen, J., Koistinen, P., Joensuu, T., Saikku, P., Karttunen, R. (2002). Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin. Exp. Immunol. 128:326-332.
23. Knaus, W.A., Draper, E.A., Wagner, D.P., Zimmerman, J.E. (1985). APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829.
24. Koenig, W., Khuseyinova, N., Hoffmann, M.M., Marz, W., Frohlich, M., Hoffmeister, A., Brenner, H., Rothenbacher, D. (2002). CD14 C(?260) aT polymorphism plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J. Am. College Cardiol. 40:34-42.
25. Lahiri, D.K., Nernberger Jr, J.I. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl. Acid Res. 19: 5444.
26. Landmann, R., Reber, A.M., Sansano, S., Zimmerli, W. (1996). Function of soluble CD14 in serum from patients with septic shock. J. Infect. Dis. 173:661-668.
27. Landmann, R., Zimmerli, W., Sansano, S., Link, S., Hahn, A., Glauser, M. P., Calandra, T. (1995). Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171(3):639-644.
28. Le Van, T.D., Bloom, J.W., Bailey, T.J., Karp, C.L., Halonen, M., Martinez, F.D., Vescelli, D. (2001). A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167(10):5838-5844.
29. Le-Barillec, K., Si-Tahar, M., Balloy, V., Chignard, M. (1999). Proteolysis of monocyte CD14 by human leucocyte elastase inhibits lipopolysaccharide-mediated cell activation. J. Clin. Invest. 103:1039-1046.
30. Lin, J., Yao, Y.M., Huang, Z.H., Hou, X.X., Zhu, J.M., Chai, J.K. (2004). Association between a genomic polymorphism within the CD14 locus and severe sepsis susceptibility as well as prognosis in patients after extensive burns. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16:271-273.
31. Lin, J., Yao, Y., Yu, Y., Chai, J., Huang, Z., Dong, N., Sheng, Z. (2007). Effects of CD14-159 C/T polymorphism on CD14 expression and the balance between proinflammatory and anti-inflammatory cytokines in whole blood culture. Shock 28(2):148-153.
32. Opal, S.M., Cohen, J. (1999). Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit. Care Med. 27:1608-1616.
33. Rivera-Chavez, F.A., Peters-Hybki, D.L., Barber, R.C., Lindberg, G.M., Jialal, I., Munford, R.S., O'Keefe, G.E. (2004). Innate immunity genes influence the severity of acute appendicitis. Ann. Surg. 240:269-277.
34. Schütt, C. (1999). Molecules in focus: CD14. Inter. J. Cell Biol. 31:45-49.
35. Tsujimoto, H., Ono, S., Majima, T., Kawarabayashi, N., Takayama, E., Kinoshita, M., Seki, S., Hiraide, H., Moldawer, L.L., Mochizuki, H. (2005). Neutrophil elastase, Mip-2, And Tlr-4 expression during human and experimental sepsis. Shock 23(1):39-44.
36. Zhang, D.E., Hetherington, C., Tan, S., Dziennis, S.E., Gonzalez, D.A., Chen, H.M., Tenen, D.G. (1994). Sp1 is critical factor for the monocyte specific expression of human CD14. J. Biol. Chem. 269:11425-11434.
37. Ziegler-Heitbrock, H.W.L., Ulevitch, R.J. (1993). CD14: Cell surface receptor and differentiation marker. Immunol. Today 14:121-125.